Orgenesis Inc. (NASDAQ: ORGS)
$0.71
+0.0099 ( +1.41% ) 38.6K
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Octomera and Therapies.
Market Data
Open
$0.71
Previous close
$0.70
Volume
38.6K
Market cap
$33.05M
Day range
$0.70 - $0.74
52 week range
$0.25 - $1.31
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Oct 31, 2023 |
8-k | 8K-related | 13 | Oct 05, 2023 |
8-k | 8K-related | 12 | Oct 03, 2023 |
3 | Insider transactions | 1 | Sep 07, 2023 |
3 | Insider transactions | 1 | Sep 05, 2023 |
4 | Insider transactions | 1 | Sep 05, 2023 |
8-k | 8K-related | 13 | Sep 01, 2023 |
10-q | Quarterly Reports | 60 | Aug 10, 2023 |
8-k | 8K-related | 13 | Jul 12, 2023 |
8-k | 8K-related | 14 | Jul 07, 2023 |